Neelu Batra • UC Davis Profiles (original) (raw)

  1. Design, expression, purification, and application of novel recombinant miR-491 molecules to define the biogenesis and function of miR-491-3p versus -5p in posttranscriptional regulation of UDP-glucuronosyltransferase 1A1. Drug Metab Dispos. 2026 Apr 04; 54(5):100292. Wang Y, Tu MJ, Batra N, Guan S, Zhou Y, Yu AM. PMID: 42066733.
    View in: PubMed Mentions:
  2. The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis. Molecules. 2025 Aug 08; 30(16). Hairston DWS, Sridharan-Weaver S, Gandhi A, Batra N, Durbin-Johnson BP, Dall'Era MA, Ghosh PM. PMID: 40871470; PMCID: PMC12388815.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  3. ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer. Mol Cancer Res. 2025 Jul 02; 23(7):585-596. Lucchesi CA, Mantrala S, Tran D, Batra N, Durve A, Suen C, Zhang J, Ghosh P, Chen X. PMID: 40052999; PMCID: PMC12221813.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  4. In Vivo Fermentation Production of RNA Interference Agents. Methods Mol Biol. 2025; 2965:489-500. Batra N, Tu MJ, Yu AM. PMID: 40877523; PMCID: PMC12888826.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  5. Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapy. Mol Pharmacol. 2025 Jan; 107(1):100006. Traber GM, Tu MJ, Guan S, Batra N, Yu AM. PMID: 39919164; PMCID: PMC13095476.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  6. Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines. Int J Mol Sci. 2024 Aug 07; 25(16). Vasilatis DM, Batra N, Lucchesi CA, Abria CJ, Packeiser EM, Murua Escobar H, Ghosh PM. PMID: 39201315; PMCID: PMC11354774.
    View in: PubMed Mentions: Fields:
    Translation:AnimalsCells
  7. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA. 2024 05 16; 30(6):680-694. Traber GM, Yi C, Batra N, Tu MJ, Yu AM. PMID: 38429100; PMCID: PMC11098458.
    View in: PubMed Mentions: 3 Fields:
    Translation:Cells
  8. Molecular Engineering of Functional SiRNA Agents. ACS Synth Biol. 2024 06 21; 13(6):1906-1915. Batra N, Tu MJ, Yu AM. PMID: 38733599; PMCID: PMC11197084.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansCells
  9. Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nat Commun. 2024 01 04; 15(1):255. Luo Z, Huang Y, Batra N, Chen Y, Huang H, Wang Y, Zhang Z, Li S, Chen CY, Wang Z, Sun J, Wang QJ, Yang D, Lu B, Conway JF, Li LY, Yu AM, Li S. PMID: 38177179; PMCID: PMC10766965.
    View in: PubMed Mentions: 13 Fields:
    Translation:HumansAnimalsCells
  10. Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer. Acta Pharm Sin B. 2023 Oct; 13(10):4273-4290. Chen Y, Tu MJ, Han F, Liu Z, Batra N, Lara PN, Chen HW, Bi H, Yu AM. PMID: 37799388; PMCID: PMC10547963.
    View in: PubMed Mentions: 7
  11. Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]. Acta Pharm Sin B. 2023 Aug; 13(8):3577-3578. Deng L, Petrek H, Tu MJ, Batra N, Yu AX, Yu AM. PMID: 37655312; PMCID: PMC10465936.
    View in: PubMed Mentions:
  12. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. J Biol Chem. 2023 08; 299(8):104973. Jathal MK, Siddiqui S, Vasilatis DM, Durbin Johnson BP, Drake C, Mooso BA, D'Abronzo LS, Batra N, Mudryj M, Ghosh PM. PMID: 37380074; PMCID: PMC10407237.
    View in: PubMed Mentions: 5 Fields:
    Translation:HumansCells
  13. Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Mol Cancer Ther. 2022 10 07; 21(10):1594-1607. Ning S, Liu C, Lou W, Yang JC, Lombard AP, D'Abronzo LS, Batra N, Yu AM, Leslie AR, Sharifi M, Evans CP, Gao AC. PMID: 35930737; PMCID: PMC9547958.
    View in: PubMed Mentions: 14 Fields:
    Translation:HumansCells
  14. Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review. Ann Transl Med. 2022 Jul; 10(13):754. Batra N, Kumar VE, Nambiar R, De Souza C, Yuen A, Le U, Verma R, Ghosh PM, Vinall RL. PMID: 35957716; PMCID: PMC9358515.
    View in: PubMed Mentions: 3
  15. Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo. Acta Pharm Sin B. 2021 Dec; 11(12):3950-3965. Deng L, Petrek H, Tu MJ, Batra N, Yu AX, Yu AM. PMID: 35024318; PMCID: PMC8727917.
    View in: PubMed Mentions: 14
  16. In vivo fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy. Theranostics. 2021; 11(10):4858-4871. Li PC, Tu MJ, Ho PY, Batra N, Tran MML, Qiu JX, Wun T, Lara PN, Hu X, Yu AX, Yu AM. PMID: 33754032; PMCID: PMC7978307.
    View in: PubMed Mentions: 19 Fields:
    Translation:HumansAnimalsCells
  17. Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth. Biochem Pharmacol. 2021 07; 189:114392. Petrek H, Yan Ho P, Batra N, Tu MJ, Zhang Q, Qiu JX, Yu AM. PMID: 33359565; PMCID: PMC8187260.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansAnimals
  18. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs. Methods Mol Biol. 2021; 2323:249-265. Tu MJ, Wright HK, Batra N, Yu AM. PMID: 34086286; PMCID: PMC9516694.
    View in: PubMed Mentions: 6 Fields:
    Translation:CellsPHPublic Health
  19. The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19). Int J Mol Sci. 2020 Sep 03; 21(17). Batra N, De Souza C, Batra J, Raetz AG, Yu AM. PMID: 32899231; PMCID: PMC7503392.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansAnimalsCellsPHPublic Health
  20. Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells. Biomedicines. 2020 Aug 11; 8(8). Batra N, Sam A, Woldemariam T, Talbott G, de Vere White RW, Ghosh PM, Gaikwad NW, Kotchoni SO, Vinall RL. PMID: 32796613; PMCID: PMC7460199.
    View in: PubMed Mentions: 4
  21. Novel approaches for efficient in vivo fermentation production of noncoding RNAs. Appl Microbiol Biotechnol. 2020 Mar; 104(5):1927-1937. Yu AM, Batra N, Tu MJ, Sweeney C. PMID: 31953559; PMCID: PMC7385725.
    View in: PubMed Mentions: 16 Fields:
    Translation:Cells
  22. Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. Acta Pharm Sin B. 2020 Jan; 10(1):159-170. Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu AX, Yu AM. PMID: 31993313; PMCID: PMC6976971.
    View in: PubMed Mentions: 41
  23. A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells. Cancer Res. 2020 02 01; 80(3):418-429. Umeh-Garcia M, Simion C, Ho PY, Batra N, Berg AL, Carraway KL, Yu A, Sweeney C. PMID: 31694904; PMCID: PMC7002233.
    View in: PubMed Mentions: 33 Fields:
    Translation:HumansAnimalsCells
  24. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs. Appl Microbiol Biotechnol. 2019 Aug; 103(15):6107-6117. Petrek H, Batra N, Ho PY, Tu MJ, Yu AM. PMID: 31187211; PMCID: PMC7068804.
    View in: PubMed Mentions: 17 Fields:
    Translation:HumansCells
  25. Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression. Acta Pharm Sin B. 2019 May; 9(3):639-647. Li X, Tian Y, Tu MJ, Ho PY, Batra N, Yu AM. PMID: 31193825; PMCID: PMC6543075.
    View in: PubMed Mentions: 43
  26. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy. J Pharmacol Exp Ther. 2018 06; 365(3):494-506. Ho PY, Duan Z, Batra N, Jilek JL, Tu MJ, Qiu JX, Hu Z, Wun T, Lara PN, DeVere White RW, Chen HW, Yu AM. PMID: 29602831; PMCID: PMC5931433.
    View in: PubMed Mentions: 44 Fields:
    Translation:AnimalsCells
  27. Mechanism of gallic acid biosynthesis in bacteria (Escherichia coli) and walnut (Juglans regia). Plant Mol Biol. 2011 Apr; 75(6):555-65. Muir RM, Ibáñez AM, Uratsu SL, Ingham ES, Leslie CA, McGranahan GH, Batra N, Goyal S, Joseph J, Jemmis ED, Dandekar AM. PMID: 21279669; PMCID: PMC3057006.
    View in: PubMed Mentions: 38 Fields:
    Translation:AnimalsCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs